NRT or Nicotine Replacement Therapies
In the UK, smokers wanting an aid to quitting can choose from a wide range of nicotine replacement therapies (NRT) including gum, patches and inhalers. NRT is a highly cost effective life-preserving intervention and is available from pharmacists on general sale or by prescription.
In 2005 the licensing arrangements for Nicotine Replacement Therapies (NRT) were changed to widen access to the therapies and remove some of the contra-indications that had previously been applied.
ASH supports these changes and produced guidance for health professionals, on these changes.
Nicotine Replacement Therapy - VAT reduction and sales of NRT
This report examines the impact of the reduction in VAT on sales of NRT
Nicotine Replacement Therapy: Guidance for health professionals on changes in the licensing arrangements for NRT
Nicotine Replacement Therapy: Guidance for health professionals on changes in the licensing arrangements for NRT
NRT: UK Marketing Review
This report commissioned by ASH aims to summarise the current NRT market in the UK, and to review current status from a consumer and trade perspective
Sample Patient Group Direction (PGD) allowing supply of NRT by health professionals other than doctors
This document from the Pharmacy Healthcare Scheme shows health professionals other than doctors can be authorised to supply NRT. The PGD establish permission to supply and a protocol under which the person who is supplying must act.
Latest Archived Items - access the rest of the archive here
Guidance on NRT and Bupropion (Zyban) (External Web Page)
2002/02 National Institute of Clinical Excellence (NICE) recommends use of smoking cessation therapies. NICE gives unequivocal endorsement to the use of Nicotine replacement therapies or Buproprion (Zyban) for smokers who wish to quit.
Letter on NRT and specialist services to smoking cessation co-ordinators
Following the National Plan, this clarifies the Department's intention to go out to consult about the deblacklisting of NRT and discusses implications for the smoking cessation services
NICE Technology Appraisal Guidance - Bupropion and NRT (External Web Page)
Guidance by National Institute of Clinical Excellence (NICE) Technology Appraisal Guidance No. 38 Smoking cessation - bupropion and nicotine replacement therapy. Technology Appraisal Guidance TGA39 Smoking cessation - bupropion and nicotine replacement therapy.
Issue Date: March 2002 Review Date: March 2005
